Casey et al. Constitutively Active Mutant 5HT2A Receptors, Society For Neuroscience Abstracts 22(3):699.10, Nov. 1996.* |
Kehne et al., Preclinical Characterization of the Potential of the Putative Atypical Antipsychotic MDL 100,907 as a Potent 5-HT2A Antagonist with a Favorable CNS Safety Profile, JPET 277:968-981 (1996). |
Egan et al., Creation of a Constitutively Activated State of the 5-Hydroxytryptamine2A Receptor by Site-Directed Mutagenesis: Inverse Agonist Activity of Antipsychotic Drugs, JPET 286:85-90 (1998). |
Egan et al., Creation of a Constitutively Activated State of the 5-HT2A Receptor by Site-directed Mutagenesis: Revelation of Inverse Agonist Activity of Antagonists, Annals NY Acad. Sci. 861:136-139 (1998). |
Pauwels, et al., “Review: Amino Acid Domains Involved in Constitutive Activation of G-Protein-Coupled Receptors,” Molecular Neurobiology, 1998, Humana Press, pp. 109-135. |
Shenker, et al., “A constitutively activiating mutation of the luteinizing hormone receptor in familial male precocious puberty,” Nature, vol. 365, Oct. 14, 1993, pp. 652-654. |
Eggerickx, et al., “Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase,” Biochemical Journal, GB, Portland Press, vol. 309, 1995, pp. 837-843. |
Grotewiel, et al., “Receptors Exhibit Constitutive Activity That is Blocked by Inverse Agonist”, Faseb Journal, Vo. 8, No. 7, May 21-25, 1994, p. A1319. |